455 related articles for article (PubMed ID: 9393971)
21. Activation of different Wnt/beta-catenin signaling components in mammary epithelium induces transdifferentiation and the formation of pilar tumors.
Miyoshi K; Rosner A; Nozawa M; Byrd C; Morgan F; Landesman-Bollag E; Xu X; Seldin DC; Schmidt EV; Taketo MM; Robinson GW; Cardiff RD; Hennighausen L
Oncogene; 2002 Aug; 21(36):5548-56. PubMed ID: 12165853
[TBL] [Abstract][Full Text] [Related]
22. Syndecan-1 is required for Wnt-1-induced mammary tumorigenesis in mice.
Alexander CM; Reichsman F; Hinkes MT; Lincecum J; Becker KA; Cumberledge S; Bernfield M
Nat Genet; 2000 Jul; 25(3):329-32. PubMed ID: 10888884
[TBL] [Abstract][Full Text] [Related]
23. Mouse mammary tumor virus p75 and p110 CUX1 transgenic mice develop mammary tumors of various histologic types.
Cadieux C; Kedinger V; Yao L; Vadnais C; Drossos M; Paquet M; Nepveu A
Cancer Res; 2009 Sep; 69(18):7188-97. PubMed ID: 19738070
[TBL] [Abstract][Full Text] [Related]
24. Functional mammary gland development and oncogene-induced tumor formation are not affected by the absence of the retinoblastoma gene.
Robinson GW; Wagner KU; Hennighausen L
Oncogene; 2001 Oct; 20(48):7115-9. PubMed ID: 11704837
[TBL] [Abstract][Full Text] [Related]
25. Wnt-4 expression induces a pregnancy-like growth pattern in reconstituted mammary glands in virgin mice.
Bradbury JM; Edwards PA; Niemeyer CC; Dale TC
Dev Biol; 1995 Aug; 170(2):553-63. PubMed ID: 7649383
[TBL] [Abstract][Full Text] [Related]
26. Preferential activation of Fgf8 by proviral insertion in mammary tumors of Wnt1 transgenic mice.
Kapoun AM; Shackleford GM
Oncogene; 1997 Jun; 14(24):2985-9. PubMed ID: 9205106
[TBL] [Abstract][Full Text] [Related]
27. Overexpression and forced activation of stat5 in mammary gland of transgenic mice promotes cellular proliferation, enhances differentiation, and delays postlactational apoptosis.
Iavnilovitch E; Groner B; Barash I
Mol Cancer Res; 2002 Nov; 1(1):32-47. PubMed ID: 12496367
[TBL] [Abstract][Full Text] [Related]
28. Human Cripto-1 overexpression in the mouse mammary gland results in the development of hyperplasia and adenocarcinoma.
Wechselberger C; Strizzi L; Kenney N; Hirota M; Sun Y; Ebert A; Orozco O; Bianco C; Khan NI; Wallace-Jones B; Normanno N; Adkins H; Sanicola M; Salomon DS
Oncogene; 2005 Jun; 24(25):4094-105. PubMed ID: 15897912
[TBL] [Abstract][Full Text] [Related]
29. Fgf10 is an oncogene activated by MMTV insertional mutagenesis in mouse mammary tumors and overexpressed in a subset of human breast carcinomas.
Theodorou V; Boer M; Weigelt B; Jonkers J; van der Valk M; Hilkens J
Oncogene; 2004 Aug; 23(36):6047-55. PubMed ID: 15208658
[TBL] [Abstract][Full Text] [Related]
30. beta-catenin is a downstream effector of Wnt-mediated tumorigenesis in the mammary gland.
Michaelson JS; Leder P
Oncogene; 2001 Aug; 20(37):5093-9. PubMed ID: 11526497
[TBL] [Abstract][Full Text] [Related]
31. Activation of both Wnt-1 and Fgf-3 by insertion of mouse mammary tumor virus downstream in the reverse orientation: a reappraisal of the enhancer insertion model.
Clausse N; Baines D; Moore R; Brookes S; Dickson C; Peters G
Virology; 1993 May; 194(1):157-65. PubMed ID: 8386870
[TBL] [Abstract][Full Text] [Related]
32. In vitro and in vivo antisense-mediated growth inhibition of a mammary adenocarcinoma from MMTV-neu transgenic mice.
Sacco MG; Barbieri O; Piccini D; Noviello E; Zoppé M; Zucchi I; Frattini A; Villa A; Vezzoni P
Gene Ther; 1998 Mar; 5(3):388-93. PubMed ID: 9614559
[TBL] [Abstract][Full Text] [Related]
33. Hyperplasia of mouse mammary epithelium induced by expression of the Wnt-1 (int-1) oncogene in reconstituted mammary gland.
Edwards PA; Hiby SE; Papkoff J; Bradbury JM
Oncogene; 1992 Oct; 7(10):2041-51. PubMed ID: 1408145
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of the retinoic acid-responsive gene Stra6 in human cancers and its synergistic induction by Wnt-1 and retinoic acid.
Szeto W; Jiang W; Tice DA; Rubinfeld B; Hollingshead PG; Fong SE; Dugger DL; Pham T; Yansura DG; Wong TA; Grimaldi JC; Corpuz RT; Singh JS; Frantz GD; Devaux B; Crowley CW; Schwall RH; Eberhard DA; Rastelli L; Polakis P; Pennica D
Cancer Res; 2001 May; 61(10):4197-205. PubMed ID: 11358845
[TBL] [Abstract][Full Text] [Related]
35. Constitutive expression of a truncated INT3 gene in mouse mammary epithelium impairs differentiation and functional development.
Smith GH; Gallahan D; Diella F; Jhappan C; Merlino G; Callahan R
Cell Growth Differ; 1995 May; 6(5):563-77. PubMed ID: 7544153
[TBL] [Abstract][Full Text] [Related]
36. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice.
Wang TC; Cardiff RD; Zukerberg L; Lees E; Arnold A; Schmidt EV
Nature; 1994 Jun; 369(6482):669-71. PubMed ID: 8208295
[TBL] [Abstract][Full Text] [Related]
37. Localization and quantification of Wnt-2 gene expression in mouse mammary development.
Bühler TA; Dale TC; Kieback C; Humphreys RC; Rosen JM
Dev Biol; 1993 Jan; 155(1):87-96. PubMed ID: 8416847
[TBL] [Abstract][Full Text] [Related]
38. Establishment and characterization of immortalized non-transplantable mouse mammary cell lines cloned from a MMTV-induced tumor cell line cultured for a long duration.
Takenaka T; Saga S; Miyaishi O; Imai M; Yokoi T; Lu J; Wajjwalku W; Kusakabe M; Taguchi O; Matsuyama M
Nagoya J Med Sci; 1991 Mar; 53(1-4):9-21. PubMed ID: 1666666
[TBL] [Abstract][Full Text] [Related]
39. Transcriptional cooperation between the transforming growth factor-beta and Wnt pathways in mammary and intestinal tumorigenesis.
Labbé E; Lock L; Letamendia A; Gorska AE; Gryfe R; Gallinger S; Moses HL; Attisano L
Cancer Res; 2007 Jan; 67(1):75-84. PubMed ID: 17210685
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of the colony-stimulating factor (CSF-1) and/or its receptor c-fms in mammary glands of transgenic mice results in hyperplasia and tumor formation.
Kirma N; Luthra R; Jones J; Liu YG; Nair HB; Mandava U; Tekmal RR
Cancer Res; 2004 Jun; 64(12):4162-70. PubMed ID: 15205327
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]